ResMed $RMD (-0.03%)
RMD operates in the healthcare sector and offers devices and software for sleep and respiratory therapies.
The share has recorded a CAGR of 13.5 % since 2001but has fallen by 17 % since the beginning of the year.
Reasons for the attractiveness of RMD:
- 5-year key figures:
- Sales CAGR: 11,84 %
- Free cash flow CAGR: 26,82 %
- Dividend CAGR: 5,85 %
- Gross profit margin: 56,93 %
- Return on invested capital (ROIC): 16,17 %
- Liquidity: 79,41 %
- Payout ratio: 34,38 %
- Share buybacks: -0,54 %